Picture of Delta-Fly Pharma logo

4598 — Delta-Fly Pharma News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Table: Delta-Fly Pharma - 9-MTH parent results

Feb 14 (Reuters)- 
             Delta-Fly Pharma, Inc. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended        Year to   
                Dec 31, 2019        Dec 31, 2018       Mar 31, 2020  
                   LATEST             YEAR-AGO            LATEST     
                   RESULTS             RESULTS           FORECAST    
  Operating       loss 1.22         loss 424 mln        loss 1.07    
  Recurring       loss 1.23         loss 501 mln        loss 1.07    
  Net             loss 1.23         loss 503 mln        loss 1.07    
  EPS          loss 276.70 yen     loss 131.63 yen   loss 244.85 yen 
  Ann Div                                NIL               NIL       
  -Q2 div            NIL                 NIL                         
  -Q4 div                                NIL               NIL       
  
  NOTE - Delta-Fly Pharma, Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4598.T

Recent news on Delta-Fly Pharma

See all news